Cost-benefit analysis of an intensive adverse product reactions monitoring program of inpatients in Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 37, Issue 4, 2006, Pages 812-819

  Tasila, Janejira ^a   Permsuwan, Unchalee ^b  

^a Chiang Kham Hospital   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750210616     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Akaleephan C, Daewpanukrungsi W, Limwattananon C. Adverse drug reaction monitoring program. J Health Sci 2004; 13: 350-61.
2. Anuwong W. Adverse drug reaction monitoring in Children's Hospital. Bangkok: Mahidol University, 1993: 154 pp. MS Thesis.
3. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals. Pharmacotherapy 2000; 20: 609-21.
4. Bootman JL, Townsend RJ, McGhan WF. Principles of pharmacoeconomics. Ohio: Harvey Whitney Books, 1999.
5. Chiewchantanakit D. Study of adverse drug reactions at Queen Sirikit National Institute of Child Health. Bangkok: Mahidol University, 2000: 168 pp. MS Thesis.
6. Choppradit C. Costs of adverse drug reactions in Samutsakhon Hospital. Khon Kaen: Khon Kaen University, 2000: 117 pp. MS Thesis.
7. Dhana N. Drug-related hospital admission at Siriraj Hospital. Bangkok: Mahidol University, 1997: 116 pp. MS Thesis.
8. Indrachai-ea S. Comparing adverse drug reaction monitoring system between alerting order system and intensive monitoring system in medical wards, King Chulalongkorn Memorial Hospital. Bangkok: Chulalongkorn University, 2000: 194 pp. MS Thesis.
9. Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health-Syst Pharm 1997; 54: 554-8.
10. Johnson JA, Bootman JL. Drug-related morbidity and mortality. Arch Intern Med 1995; 155: 1949-56.
11. Jolicoeur LM, Jones-Grizzle AJ, Boyer G. Guidelines for performing a pharmacoeconomic analysis. Am J Hosp Pharm 1992; 49: 1741-7.
12. Khunkaewla P, Permsuwan U. Prevalence and classification of adverse drug reactions of inpatients in female medical ward. Thai J Hospital Pharm 2004; 14: 200-10.
13. Lipscomb J, Weinstein MC, Torrance GW. Time preference. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996: 214-46.
14. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.
15. Nesbit TW, Shermock KM, Bobek MB, et al. Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model. Am J Health Syst Pharm 2001; 58: 784-90.
16. Panrong A. Incidence and cost impact of adverse drug reaction at Queen Sirikit National Institute of Child Health. Bangkok: Mahidol University, 1999: 106 pp. MS Thesis.
17. Pomyen N. Characteristics of adverse drug reactions and patients at risk in medical wards, Ramathibodi Hospital. Bangkok: Mahidol University, 2002: 176 pp. MS Thesis.
18. Pongwecharak J. Intensive hospital monitoring of adverse drug reaction. Bangkok: Mahidol University, 1991: 127 pp. MS Thesis.
19. Pongwecharak J, Kanjanakul S, Sitthidetch Y, Apiromrak P. Gastrointestinal adverse drug effects in patients admitted to Songklanakarind Hospital. Songkla Med J 1999; 17: 15-23.
20. Prommeenate W. Cost-benefit analysis of adverse drug reaction monitoring program at Lerdsin Hospital in 1999. Bangkok: Mahidol University; 2000: 113 pp. MS Thesis.
21. Rawlins MD, Thompson JW. Pathogenesis of adverse drug reaction. In: David DM, ed. Textbook of adverse drug reaction. New York: Oxford University Press, 1997: 10.
22. Rowland M, Tozer TN. Clinical pharmacokinetics concepts and applications. Philadelphia, USA: Willians and Wilkins Rose tree Coperate Center, 1995: 19-20.
23. Schumock GT, Thornton JP. Focusing on the preventablility of adverse drug reactions. Hosp Pharm 1992; 27: 538.
24. Siriruttanapruk S. Drug-related hospital admissions in elderly patients of medical ward at Ramathibodi Hospital. Bangkok: Mahidol University, 1999: 96 pp. MS Thesis.
25. Sullivan SD, Kreling DH, Hazlet TK. Noncompliance with medication regimens and subsequent hospitalization. A literature analysis and cost of hospitalization estimate. J Res Pharm Econ 1990; 2: 19-33.
26. Tragulpiankit P. In-patient adverse drug reaction monitoring at the department of medicine, Ramathibodi Hospital. Bangkok: Mahidol University, 1995: 112 pp. MS Thesis.
27. Thai Food and Drug Administration [Online]. Introduce APR center: History. [Cited 2005 Nov 8]. Available at: URL: http://www.fda.moph.go.th /fda-net/html/product/apr/APRhistory.htm
28. Winter ME. Basic clinical pharmacokinetics. Washington: Applied Therapeutics, 1994: 45-56.
29. Yaemphaka B. Pharmacist's prescription screening program to detect adverse drug reactions. Bangkok: Mahidol University, 2000: 140 pp. MS Thesis.